Skip to main content
SpringerLink
Log in

The Successful Use of Adalimumab to Treat Active Crohn's Disease of an Ileoanal Pouch During Pregnancy

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Fonager K, Sorensen HT, Olsen J, Dahlerup JF, Rasmussen SN (1998) Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 93:2426–2430

    Article  PubMed  CAS  Google Scholar 

  2. Rau R (2002) Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials. Ann Rheum Dis 61(suppl 2):ii70–73

    Google Scholar 

  3. Weinblatt ME, Keystone EC, Furst DE, et al. (2003) Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48:35–45

    Article  PubMed  CAS  Google Scholar 

  4. Weinblatt ME, Keystone EC, Furst DE, Kavanaugh AF, Chartash EK, Segurado OG (2006) Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study. Ann Rheum Dis 65:753–759

    Article  PubMed  CAS  Google Scholar 

  5. Weisman MH, Moreland LW, Furst DE, et al. (2003) Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study. Clin Ther 25:1700–1721

    Article  PubMed  CAS  Google Scholar 

  6. Sandborn WJ, Hanauer S, Loftus EV Jr, et al. (2004) An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease. Am J Gastroenterol 99:1984–1989

    Article  PubMed  CAS  Google Scholar 

  7. Papadakis KA, Shaye OA, Vasiliauskas EA, et al. (2005) Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab. Am J Gastroenterol 100:75–79

    Article  PubMed  CAS  Google Scholar 

  8. Mahadevan U, Kane S, Sandborn WJ, et al. (2005) Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 21:733–738

    Article  PubMed  CAS  Google Scholar 

  9. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR (2004) Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 99:2385–2392

    Article  PubMed  Google Scholar 

  10. Treacy G (2000) Using an analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNFalpha monoclonal antibody. Hum Exp Toxicol 19:226–228

    Article  PubMed  CAS  Google Scholar 

  11. Hanauer S, Lukas M, MacIntosh D, Rutgeerts P, Sandborn WJ, Pollack P (2004) A randomized, double-blind, placebo-controlled trial of the human anti-TNF- alpha monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn's disease. Gastroenterology 27:A332

    Article  Google Scholar 

  12. Sandborn WJ, Hanauer S, Lukas M, et al. (2005) Induction and maintenance of clinical response in subjects with Crohn's disease treated during a 6-month open-label period with fully humanized anti-TNF alpha monoclonal antibody adalimumab. Gastroenterology 128:A-111

    Google Scholar 

  13. Baidoo L, Lichtenstein GR (2005) What next after infliximab? Am J Gastroenterol 100:80–83

    Article  PubMed  CAS  Google Scholar 

  14. Youdim A, Vasiliauskas EA, Targan SR, et al. (2004) A pilot study of adalimumab in infliximab-allergic patients. Inflamm Bowel Dis 10:333–338

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Inflammatory Bowel Disease Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    Lori A. Coburn & Paul E. Wise

  2. Inflammatory Bowel Disease Center; Division of Gastroenterology, Vanderbilt University Medical Center, 1501 TVC, Nashville, TN, 37232, USA

    David A. Schwartz

Authors
  1. Lori A. Coburn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul E. Wise
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David A. Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David A. Schwartz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coburn, L.A., Wise, P.E. & Schwartz, D.A. The Successful Use of Adalimumab to Treat Active Crohn's Disease of an Ileoanal Pouch During Pregnancy. Dig Dis Sci 51, 2045–2047 (2006). https://doi.org/10.1007/s10620-006-9452-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9452-2

Keywords

Search

Navigation